Tariff Impact Analysis forDrug Delivery Market Stay ahead as Tariffs Reshape Trade. Get Expert Insights and UpdatesRequest Now
Does the Italian prime minister have what it takes to get Europe a tariff break? Aneeta Mathur-Ashton April 17, 2025 Lunch Break: Hold On to Your Chianti Builders are grappling with elevated mortgage rates and high prices as well as uncertainty over p...
It’s Day One of Trump’s new tariff regime, and the rest of the world is not happy. Aneeta Mathur-Ashton April 9, 2025 Lunch Break: Day One of Trade War I JPMorgan CEO Jamie Dimon joins a chorus of business leaders warning of economic downturn, says recession ...
Harris calls tariff war the "greatest man-made economic crisis in modern presidential history" The San Francisco speech was the former vice president's first major public remarks since losing the November election to President Trump. May 1
NanoVibronix, Inc. today announced that its application for UroShield actuators to be available on NHS Prescription Services’ Drug Tariff has been approved.
In this region, North America ruled the global drug discovery market, as it accounted for a larger share of 42.1% in 2023. You May Also Like To Read Vitamins And Supplements Statistics Health Care Devices Statistics Skincare Statistics Health And Fitness Statistics PTSD Statistics Personal Hygiene...
Tariff Pause Reinforces Uncertainty Among Biopharma Professionals PharmTech News Capsida Previews Its Oral and Poster Presentations for ASGCT 2025 Patrick Lavery April 30th 2025 Article The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturin...
UnitedHealthcare may put Journavx on a non-preferred tier on its list of approved drugs, resulting in most insured people paying 20% coinsurance. Vertex priced Journavx at $31 per day. “There’s almost no not covering these drugs, due to the pressures we’re getting,” a UnitedHealth ...
(dimethylamino)but-2-enamido)picolinamide HS Tariff Code: 2934.99.9001 Syros Molecular Weight 587.12 Formula C₃₁H₃₅ClN₈O₂ OriginatorSyros Pharmaceuticals ClassAmides; Amines; Antineoplastics; Chlorinated hydrocarbons; Cyclohexanes; Indoles; Pyridines; Pyrimidines; Small molecules Mechanism ...
In May 2023, KDCA announced a strategy focused on the rapid development of treatments for a range of infectious diseases to control them early . The strategy targets eight critical viruses: severe fever with thrombocytopenia syndrome (SFTS), influenza, Covid-19, Middle East respiratory syndrome co...